These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17594758)

  • 1. Zonisamide and renal calculi in patients with epilepsy: how big an issue?
    Wroe S
    Curr Med Res Opin; 2007 Aug; 23(8):1765-73. PubMed ID: 17594758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zonisamide: new drug. No advantage in refractory partial epilepsy.
    Prescrire Int; 2007 Jun; 16(89):95-7. PubMed ID: 17582922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures.
    Faught E
    Seizure; 2004 Dec; 13 Suppl 1():S59-65; discussion S71-2. PubMed ID: 15511695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonisamide clinical trials: European experience.
    Brodie MJ
    Seizure; 2004 Dec; 13 Suppl 1():S66-70; discussion S71-2. PubMed ID: 15511696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued use of zonisamide following development of renal calculi.
    Richards KC; Smith MC; Verma A
    Neurology; 2005 Feb; 64(4):763-4. PubMed ID: 15728320
    [No Abstract]   [Full Text] [Related]  

  • 7. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
    Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of zonisamide therapy: prospective follow-up survey.
    Ohtahara S; Yamatogi Y
    Seizure; 2004 Dec; 13 Suppl 1():S50-5; discussion S56. PubMed ID: 15511692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.
    Schmidt D; Jacob R; Loiseau P; Deisenhammer E; Klinger D; Despland A; Egli M; Bauer G; Stenzel E; Blankenhorn V
    Epilepsy Res; 1993 May; 15(1):67-73. PubMed ID: 8325280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide monotherapy for epilepsy in children and young adults.
    Wilfong AA
    Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug safety evaluation of zonisamide for the treatment of epilepsy.
    Zaccara G; Tramacere L; Cincotta M
    Expert Opin Drug Saf; 2011 Jul; 10(4):623-31. PubMed ID: 21663459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zonisamide for the treatment of epilepsy.
    Arzimanoglou A; Rahbani A
    Expert Rev Neurother; 2006 Sep; 6(9):1283-92. PubMed ID: 17009916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum to "Safety of zonisamide therapy: prospective follow-up survey.".
    Ohtahara S; Yamatogi Y
    Seizure; 2007 Jan; 16(1):87-93. PubMed ID: 17269155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of zonisamide: results of a multicenter study.
    Leppik IE; Willmore LJ; Homan RW; Fromm G; Oommen KJ; Penry JK; Sackellares JC; Smith DB; Lesser RP; Wallace JD
    Epilepsy Res; 1993 Feb; 14(2):165-73. PubMed ID: 8453952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical prescribing and long-term efficacy and safety of zonisamide.
    Leppik IE
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide in pediatric epilepsy: review of the Japanese experience.
    Glauser TA; Pellock JM
    J Child Neurol; 2002 Feb; 17(2):87-96. PubMed ID: 11952083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.
    Donofrio PD; Raskin P; Rosenthal NR; Hewitt DJ; Jordan DM; Xiang J; Vinik AI;
    Clin Ther; 2005 Sep; 27(9):1420-31. PubMed ID: 16291415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.